These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 6338899

  • 1. Direct immunofluorescence in pyoderma gangrenosum.
    Powell FC, Schroeter AL, Perry HO, Su WP.
    Br J Dermatol; 1983 Mar; 108(3):287-93. PubMed ID: 6338899
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pyoderma gangrenosum vs malignant pyoderma. Lumpers vs splitters.
    Malkinson FD.
    Arch Dermatol; 1987 Mar; 123(3):333-7. PubMed ID: 3545089
    [No Abstract] [Full Text] [Related]

  • 4. Histopathologic and immunopathologic study of pyoderma gangrenosum.
    Su WP, Schroeter AL, Perry HO, Powell FC.
    J Cutan Pathol; 1986 Oct; 13(5):323-30. PubMed ID: 3537032
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pulse therapy. Therapeutic efficacy in the treatment of pyoderma gangrenosum.
    Johnson RB, Lazarus GS.
    Arch Dermatol; 1982 Feb; 118(2):76-84. PubMed ID: 7036913
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Pyoderma gangrenosum. 14 personal observations and review of the literature].
    Guilhou JJ, Guillot B, Meynadier J.
    J Mal Vasc; 1987 Feb; 12(2):202-7. PubMed ID: 3585190
    [Abstract] [Full Text] [Related]

  • 9. Cryoimmunoglobulin IgGk with microtubular ultrastructure associated with pyoderma gangrenosum.
    White JC, Adam BA, Lau KS, Horne RW, Parkhouse RM.
    J Pathol; 1976 Sep; 120(1):25-33. PubMed ID: 978311
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pyoderma gangrenosum with cellular immunity defect and red cell aplasia.
    Clayton R.
    Proc R Soc Med; 1977 Aug; 70(8):571-2. PubMed ID: 303364
    [No Abstract] [Full Text] [Related]

  • 12. The current status of pyoderma gangrenosum.
    Holt PJ.
    Clin Exp Dermatol; 1979 Dec; 4(4):509-16. PubMed ID: 394888
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Dermatitis ulcerosa (pyoderma gangraenosum). 2 cases with abnormal serum factors].
    Kovács L, Husz S, Dobozy A, Szarbó E.
    Z Hautkr; 1976 May 01; 51(09):571-81. PubMed ID: 785845
    [No Abstract] [Full Text] [Related]

  • 15. Defective monocyte function in pyoderma gangrenosum with IgG kappa paraproteinaemia.
    Jones RR, Kobza Black A, Donaghy M, Moshtael O, Pinching AJ.
    Clin Exp Immunol; 1983 Jun 01; 52(3):685-92. PubMed ID: 6409473
    [Abstract] [Full Text] [Related]

  • 16. Pyoderma gangrenosum and monoclonal gammopathy.
    Powell FC, Schroeter AL, Su WP, Perry HO.
    Arch Dermatol; 1983 Jun 01; 119(6):468-72. PubMed ID: 6859886
    [Abstract] [Full Text] [Related]

  • 17. Pyoderma gangrenosum with chronic myeloid leukaemia.
    Goldin D.
    Proc R Soc Med; 1974 Dec 01; 67(12 Pt 1):1239-40. PubMed ID: 4532236
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.